The surgeon’s new company offers prescription peptide care only after an independent licensed clinician reviews each patient.
Sheridan, WY (PRUnderground) November 12th, 2026
Dr. Terry Dubrow’s first word on peptides is a warning. “There aren’t shortcuts or magic solutions,” says Dubrow, the founder and chief medical officer of HealthRX.com, a telehealth company that launched this week.
The timing is not an accident. On Oct. 28, the U.S. Department of Health and Human Services announced an interim policy of enforcement discretion for compounding with six peptide bulk drug substances, subject to specified conditions while FDA develops its 503A bulks list through rulemaking. The policy is not FDA approval, and compounded medications are not FDA approved.
HealthRX.com offers those six. Each one is offered on its own, not in a blend. Each needs a prescription. None ships until an independent licensed clinician has reviewed the patient’s health history and decided it is appropriate.
Dubrow says that last step is the whole point. “Whether we’re talking about GLP-1s, peptides, or the next generation of medicine, there aren’t shortcuts or magic solutions,” he says. “These are real medical treatments and they deserve real medical oversight.”
HealthRX.com works like this. A patient answers questions online about their health and medical history. An independent licensed clinician reviews the answers and decides which treatment, if any, is appropriate. If a treatment is prescribed, it ships to the patient’s door, and the care team stays available for questions and adjustments. Completing the assessment does not guarantee a prescription.
Interest in peptides has grown faster than the rules around them, and Dubrow says patients should be careful about who they buy from. That includes the company he just founded.
“Look, there are a lot of telehealth companies out there,” he says in the company’s launch film. “The problem is you don’t know who’s standing behind them, who the founders are, and where they’re getting their licensed providers from.”
His advice is to check. “I think you should trust me, but always trust and verify,” Dubrow says. “There’s a lot of information online that you have access to. So even though I’m board certified, you need to trust your gut and look things up. Always research for yourself.”
The HHS policy is interim and conditional. It addresses compounding by state-licensed pharmacies for patients who have a prescription while FDA develops its bulks list. HHS may revisit the policy if safety or product-quality issues arise.
Would he send his own family to the company? “I would definitely recommend HealthRX to someone I love if they were medically eligible,” Dubrow says.
He said all of this while connected to a polygraph. The launch film puts 23 questions to him over more than 10 minutes, and its campaign line is “Don’t trust us. Test us.”
Dubrow is a board-certified plastic surgeon and has been certified by the American Board of Obesity Medicine since December 2024. He says he has taken GLP-1 medication himself and got involved because of it.
“I want to be a part of shaping that future and helping people live healthier, better lives and that’s why I’m proud to partner with HealthRX,” Dubrow says.
Prescription peptide and GLP-1 care are available now. The launch video and the online assessment are available through HealthRX.com.
About HealthRX.com
HealthRX.com is a U.S. telehealth brand launching with Dr. Terry Dubrow as founder and chief medical officer. The platform facilitates online access to independent licensed clinicians for GLP-1 and prescription peptide care. Treatment is prescribed when clinically appropriate, with delivery and continuing access to care-team support.
Media contact
Jennifer Washburn | HealthRX.com | press@healthrx.com
